Centre for Virus and Vaccine Research, School of Science and Technology, Sunway University, 47500 Subang Jaya, Selangor, Malaysia.
Int J Med Sci. 2019 Jan 24;16(3):355-365. doi: 10.7150/ijms.29938. eCollection 2019.
Dengue virus belongs to the Flaviviridae family which also includes viruses such as the Zika, West Nile and yellow fever virus. Dengue virus generally causes mild disease, however, more severe forms of the dengue virus infection, dengue haemorrhagic fever (DHF) and dengue haemorrhagic fever with shock syndrome (DSS) can also occur, resulting in multiple organ failure and even death, especially in children. The only dengue vaccine available in the market, CYD-TDV offers limited coverage for vaccinees from 9-45 years of age and is only recommended for individuals with prior dengue exposure. A number of mutations that were shown to attenuate virulence of dengue virus and/or have been identified in the literature. The mutations which fall within the conserved regions of all four dengue serotypes are discussed. This review hopes to provide information leading to the construction of a live attenuated dengue vaccine that is suitable for all ages, irrespective of the infecting dengue serotype and prior dengue exposure.
登革热病毒属于黄病毒科,该科还包括寨卡、西尼罗河和黄热病病毒等。登革热病毒通常引起轻症,但也可能出现更严重的登革热病毒感染,如登革出血热(DHF)和登革出血热伴休克综合征(DSS),导致多器官衰竭甚至死亡,尤其是在儿童中。目前市场上唯一可用的登革热疫苗 CYD-TDV 对 9-45 岁的接种者的保护作用有限,仅推荐用于有既往登革热暴露史的个体。文献中已经鉴定出一些可降低登革热病毒毒力的突变。本文讨论了所有四种登革热血清型中保守区域内的突变。本文综述希望提供相关信息,从而构建一种适合所有年龄段、无论感染的登革热血清型和既往登革热暴露情况的减毒活疫苗。